The Company uses derivative instruments, including foreign currency exchange forward contracts, interest rate swaps and CCIRs, to manage certain foreign currency and interest rate exposures. Derivative instruments are viewed as risk management tools by the Company and are not used for trading or speculative purposes. All derivative instruments are recorded on the Company's Condensed Consolidated Balance Sheets at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.

The Company primarily applies the market approach for recurring fair value measurements and endeavors to utilize the best available information. Accordingly, the Company utilizes valuation techniques that maximize the use of observable inputs, such as forward rates, interest rates, the Company’s credit risk and counterparties’ credit risks, and which minimize the use of unobservable inputs. The Company is able to classify fair value balances based on the ability to observe those inputs. Foreign currency exchange forward contracts, interest rate swaps and CCIRs are based upon pricing models using market-based inputs (Level 2). Model inputs can be verified and valuation techniques do not involve significant management judgment.


(In thousands)	Balance Sheet Location	Fair Value of Derivatives Designated as Hedging Instruments		Fair Value of Derivatives Not Designated as Hedging Instruments		Total Fair Value
June 30, 2020
Asset derivatives (Level 2):
Foreign currency exchange forward contracts	Other current assets	$	3,406	$	4,732	$	8,138


Total		$	3,406	$	4,732	$	8,138
Liability derivatives (Level 2):
Foreign currency exchange forward contracts	Other current liabilities	$	159	$	1,006	$	1,165
Interest rate swaps	Other current liabilities	3,673		—		3,673
Interest rate swaps	Other liabilities	5,336		—		5,336
Total		$	9,168	$	1,006	$	10,174
December 31, 2019
Asset derivatives (Level 2):
Foreign currency exchange forward contracts	Other current assets	$	2,039	$	946	$	2,985




Total		$	2,039	$	946	$	2,985
Liability derivatives (Level 2):
Foreign currency exchange forward contracts	Other current liabilities	$	140	$	3,733	$	3,873
Interest rate swaps	Other current liabilities	2,098		—		2,098
Interest rate swaps	Other liabilities	4,281		—		4,281
Total		$	6,519	$	3,733	$	10,252

All of the Company's derivatives are recorded on the Company's Condensed Consolidated Balance Sheets at gross amounts and not offset. All of the Company's interest rate swaps, CCIRs and certain foreign currency exchange forward contracts are transacted under ISDA documentation. Each ISDA master agreement permits the net settlement of amounts owed in the event of default. The Company's derivative assets and liabilities subject to enforceable master netting arrangements, if offset, would result in a $2.5 million net liability at June 30, 2020 and would not have resulted in a net asset or liability at


	Amount Recognized in OCI on Derivatives					Location of Amount Reclassified from AOCI into Income			Amount Reclassified from AOCI into Income - Effective Portion or Equity
	Three Months Ended										Three Months Ended
	June 30										June 30
(In thousands)	2020		2019					2020			2019
Foreign currency exchange forward contracts	$	41	$	669	Product revenues	$	(332)		$	(389)

Interest rate swaps	—		—		Income from discontinued businesses	—			2,741
Interest rate swaps	(162)		(4,327)		Interest expense	732			(271)
Cross-currency interest rate swaps (a)	5		54		Interest expense	295			303
	$	(116)	$	(3,604)		$	695		$	2,384



	Amount Recognized in OCI on Derivatives					Location of Amount Reclassified from AOCI into Income			Amount Reclassified from Accumulated OCI into Income - Effective Portion or Equity
	Six Months Ended										Six Months Ended
	June 30										June 30
(In thousands)	2020		2019					2020			2019
Foreign currency exchange forward contracts	$	2,078	$	(43)	Product revenues/Cost of services sold	$	(1,736)		$	(421)
Interest rate swaps	—		—		Income from discontinued businesses	—			2,741
Interest rate swaps	(3,740)		(7,636)		Interest expense	1,110			(572)
Cross-currency interest rate swaps (a)	63		2		Interest expense	600			617
	$	(1,599)	$	(7,677)		$	(26)		$	2,365


	Three Months Ended
	June 30
	2020						2019
(in thousands)	Product Revenues		Interest Expense		Product Revenues		Cost of Services Sold		Interest Expense		Income From Discontinued Businesses
Total amounts of line items presented in the Condensed Consolidated Statement of Operations in which the effects of cash flow hedges are recorded	$	101,703	$	(14,953)	$	112,895	$	186,840	$	(6,103)	$	9,936
Interest rate swaps:
Amount of gain or (loss) reclassified from AOCI into income	—		(732)		—		—		271		—
Amount of gain or (loss) reclassified from AOCI into income as a result that a forecasted transaction is no longer probable of occurring	—		—		—		—		—		(2,741)


	Three Months Ended
	June 30
	2020			2019
(in thousands)	Product Revenues	Interest Expense	Product Revenues	Cost of Services Sold	Interest Expense	Income From Discontinued Businesses
Foreign exchange contracts:
Amount of gain or reclassified from AOCI into income	332	—	433	(44)	—	—
Amount excluded from effectiveness testing recognized in earnings based on changes in fair value	13	—	238	—	—	—
Amount excluded from the effectiveness testing recognized in earnings based on an amortization approach	21	—	—	—	—	—
Cross-currency interest rate swaps:
Amount of loss reclassified from AOCI into income	—	(295)	—	—	(303)	—



	Six Months Ended
	June 30
	2020						2019
(in thousands)	Product Revenues		Interest Expense		Product Revenues		Cost of Services Sold		Interest Expense		Income From Discontinued Operations
Total amounts of income and expense line items presented in the statement of financial performance in which the effects of cash flow hedges are recorded	$	209,205	$	(27,602)	$	213,277	$	368,711	$	(11,610)	$	23,686
Interest rate swaps:
Amount of gain or (loss) reclassified from AOCI into income	—		(1,110)		—		—		572		—
Amount of gain or (loss) reclassified from AOCI into income as a result that a forecasted transaction is no longer probable of occurring	—		—		—		—		—		(2,741)
Foreign exchange contracts:
Amount of gain or (loss) reclassified from AOCI into income	1,736		—		465		(44)		—		—
Amount excluded from effectiveness testing recognized in earnings based on changes in fair value	196		—		316		—		—		—
Amount excluded from the effectiveness testing recognized in earnings based on an amortization approach	21		—		—		—		—		—
Cross-currency interest rate swaps:
Amount of gain or (loss) reclassified from AOCI into income	—		(600)		—		—		(617)		—


	Location of Gain Recognized in Income on Derivatives	Amount of Gain Recognized in Income on Derivatives (b)
				Three Months Ended									Six Months Ended
				June 30									June 30
(In thousands)				2020			2019			2020			2019

Foreign currency exchange forward contracts	Cost of services and products sold	$	1,736		$	2,770		$	7,278		$	5,094

The Company conducts business in multiple currencies and, accordingly, is subject to the inherent risks associated with foreign exchange rate movements. Foreign currency-denominated assets and liabilities are translated into U.S. dollars at the exchange rates existing at the respective balance sheet dates, and income and expense items are translated at the average exchange rates during the respective periods.

The Company uses derivative instruments to hedge cash flows related to foreign currency fluctuations. Foreign currency exchange forward contracts outstanding are part of a worldwide program to minimize foreign currency exchange operating income and balance sheet exposure by offsetting foreign currency exposures of certain future payments between the Company and various subsidiaries, suppliers or customers. The unsecured contracts are with major financial institutions. The Company may be exposed to credit loss in the event of non-performance by the contract counterparties. The Company evaluates the creditworthiness of the counterparties and does not expect default by them. Foreign currency exchange forward contracts are used to hedge commitments, such as foreign currency debt, firm purchase commitments and foreign currency cash flows for certain export sales transactions.

Changes in the fair value of derivatives used to hedge foreign currency denominated balance sheet items are reported directly in earnings, along with offsetting transaction gains and losses on the items being hedged. Derivatives used to hedge forecasted cash flows associated with foreign currency commitments may be accounted for as cash flow hedges, as deemed appropriate, if the criteria for hedge accounting are met. Gains and losses on derivatives designated as cash flow hedges are deferred in AOCI, a separate component of equity, and reclassified to earnings in a manner that matches the timing of the earnings impact of the hedged transactions. The ineffective portion of all hedges, if any, is recognized currently in earnings.

In addition to foreign currency exchange forward contracts, the Company designates certain loans as hedges of net investments in international subsidiaries. The Company recorded pre-tax net losses of $2.4 million and $12.1 million for the three and six months ended June 30, 2020, respectively and pre-tax net losses of $5.5 million and $0.7 million for the three and six months ended June 30, 2019, respectively, in AOCI.

The Company uses interest rate swaps in conjunction with certain variable rate debt issuances in order to secure a fixed interest rate. Changes in the fair value attributed to the effect of the swaps’ interest spread and changes in the credit worthiness of the counter-parties are recorded in AOCI.

In January 2017 and February 2018 the Company entered into a series of interest rate swaps that cover the period from 2018 through 2022 and had the effect of converting $300.0 million of the Original Term Loan from floating-rate to fixed-rate. The fixed rates provided by the swaps replace the adjusted LIBOR rate in the interest calculation, ranging from 2.45% for 2020 to 3.12% for 2022.

During June 2019 the Company effected the early termination of interest rate swaps that covered the period from 2019 through 2022 and had the effect of converting $100.0 million of the Original Term Loan from floating-rate to fixed-rate. This termination was conducted as a result of the Company's new Notes offering and required repayment of a portion of the Original Term Loan with proceeds from the AXC disposal. The total notional of the Company's interest rate swaps is $200.0 million as of June 30, 2020.

The Company may use CCIRs in conjunction with certain debt issuances in order to secure a fixed local currency interest rate. Under these CCIRs, the Company receives interest based on a fixed or floating U.S. dollar rate and pays interest on a fixed local currency rate based on the contractual amounts in dollars and the local currency, respectively. At maturity, there is also the payment of principal amounts between currencies. Changes in the fair value attributed to the effect of the swaps' interest spread and changes in the credit worthiness of the counter-parties are recorded in AOCI. Changes in value attributed to the effect of foreign currency fluctuations are recorded on the Company's Condensed Consolidated Statements of Operations and offset currency fluctuation effects on the debt principal. The Company had no outstanding CCIRs at June 30, 2020.